Linzagolix: a new GnRH-antagonist under investigation for the treatment of endometriosis and uterine myomas
Susan Dababou(University of Verona), Fabio Barra(Institute for Health Metrics and Evaluation), Massimo Piergiuseppe Franchi(University of Verona), Simone Garzon(University of Insubria), Stefano Palomba(Azienda ospedaliera "Bianchi-Melacrino-Morelli"), Maurizio Nicola D’Alterio(University of Cagliari), Giulio Evangelisti(Ospedale Policlinico San Martino), Antonio Simone Laganà(Azienda Ospedaliera Universitaria Policlinico "Paolo Giaccone" di Palermo), Marco Noventa(University of Padua), Simone Ferrero(Ospedale Policlinico San Martino), Stefano Uccella(University of Insubria)
Cited by 62
Related Papers
ESHRE guideline: endometriosis
|Human Reproduction Open|2022|1.5k
Systematic approach to sonographic evaluation of the pelvis in women with suspected endometriosis, including terms, definitions and measurements: a consensus opinion from the International Deep Endometriosis Analysis (IDEA) group
|Ultrasound in Obstetrics and Gynecology|2016|882
The burden of bacterial antimicrobial resistance in the WHO European region in 2019: a cross-country systematic analysis
|The Lancet Public Health|2022|373
Bowel Endometriosis: Presentation, Diagnosis, and Treatment
|Obstetrical & Gynecological Survey|2007|333
Early Impairment of Endothelial Structure and Function in Young Normal-Weight Women with Polycystic Ovary Syndrome
|The Journal of Clinical Endocrinology & Metabolism|2004|328